Shuai Li

机构：Hebei Medical University, Union Hospital, Regeneron (United States), Chinese Academy of Sciences, Second Hospital of Hebei Medical University, Shanghai Institute of Materia Medica, First Affiliated Hospital of Hebei Medical University, Huazhong University of Science and Technology · ORCID：0000-0001-5889-3655

发表论文 117 篇 · 总被引 2167 次 · h-index 24

代表论文

• Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma (2024 · Frontiers in Immunology · 被引 23)
• DFO-loaded PDA nanoparticles facilitated 3D stem cell spheroids for diabetic wound repair by normalizing the pathological microenvironment (2025 · Materials Today Bio · 被引 18)
• Distinct chemical degradation pathways of AAV1 and AAV8 under thermal stress conditions revealed by analytical anion exchange chromatography and LC-MS-based peptide mapping (2024 · Journal of Pharmaceutical and Biomedical Analysis · 被引 16)
• Lyophilization as an effective tool to develop AAV8 gene therapy products for refrigerated storage (2023 · International Journal of Pharmaceutics · 被引 11)
• Evaluating anti-viral effect of Ivermectin on porcine epidemic diarrhea virus and analyzing the related genes and signaling pathway by RNA-seq in vitro (2023 · Virology · 被引 8)
• Recent advances in bladder cancer stem cells (BCSCs): A descriptive review of emerging therapeutic targets (2025 · iScience · 被引 6)